GlobeNewswire 11/02/2022 Molecular Partners to Present at Upcoming Healthcare Investor Conference
GlobeNewswire 10/02/2022 Emergency Use Authorization Request for Ensovibep Submitted to the US Food and Drug Administration f...
GlobeNewswire 18/01/2022 Molecular Partners Finalizes License Agreement with Novartis for Ensovibep for COVID-19
GlobeNewswire 13/01/2022 Molecular Partners Reports Disclosure of Major Shareholder as per Swiss Stock Exchange Regulations
TeleTrader 10/01/2022 Novartis drug 78% efficient against COVID - trial
GlobeNewswire 10/01/2022 Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP042...
GlobeNewswire 05/01/2022 Molecular Partners to Present at Upcoming Healthcare Investor Conferences
GlobeNewswire 15/12/2021 Molecular Partners to Host Oncology Day (Virtual)
GlobeNewswire 14/12/2021 Molecular Partners Announces Collaboration with Novartis to Develop DARPin-Conjugated Radioligand Th...
GlobeNewswire 12/12/2021 Molecular Partners Confirms Ensovibep Retains Neutralization of Omicron Variant of SARS-CoV-2 in Pre...
GlobeNewswire 09/12/2021 Molecular Partners Highlights Upcoming Oncology Portfolio Presentations in December
GlobeNewswire 06/12/2021 Molecular Partners Presents Results from a Phase 2a Trial of Ensovibep in 12 COVID-19 Patients at ES...
GlobeNewswire 03/12/2021 Molecular Partners Announces Research Collaboration with University of Bern to Develop MP0533, a Mul...
GlobeNewswire 30/11/2021 Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omic...
GlobeNewswire 24/11/2021 Molecular Partners Announces Presentation at the Evercore ISI 4th Annual HealthCONx Conference
GlobeNewswire 16/11/2021 Molecular Partners Provides Update from ACTIV-3 Global Clinical Study of Ensovibep in Patients Hospi...
GlobeNewswire 04/11/2021 Molecular Partners Announces First Patient Dosed with CD40 Therapeutic Candidate MP0317 in Phase 1 C...
GlobeNewswire 28/10/2021 Interim Management Statement Q3 2021 of Molecular Partners: Advancement of COVID-19 Clinical Program...
GlobeNewswire 20/10/2021 Molecular Partners Present Data Demonstrating Successful Inhibition of COVID19 Viral Variants with E...
GlobeNewswire 03/09/2021 Molecular Partners to Present at Upcoming Healthcare Investor Conferences
GlobeNewswire 26/08/2021 Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021
GlobeNewswire 09/08/2021 Molecular Partners to Regain Global Rights to Abicipar
GlobeNewswire 08/07/2021 Molecular Partners Reports Continued Progress of Ensovibep Global Clinical Program; Positive in vitr...
GlobeNewswire 17/03/2021 Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...
GlobeNewswire 30/07/2020 Genespire appoints Jörn Aldag as Chairman of the Board of Directors